Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Mark Stevenson Biography and Net Worth

COO of Thermo Fisher Scientific

Mark P. Stevenson is Chief Operating Officer, Executive Vice President of the Company. Mr. Stevenson was appointed Executive Vice President and Chief Operating Officer in August 2017. He was Executive Vice President and President, Life Sciences Solutions from February 2014 to August 2017. Prior to the acquisition of Life Technologies Corporation ("Life Technologies"), Mr. Stevenson was President and Chief Operating Officer of Life Technologies from November 2008 to February 2014.

What is Mark Stevenson's net worth?: The estimated net worth of Mark Stevenson is at least $30.40 million as of December 4th, 2020. Mr. Stevenson owns 58,005 shares of Thermo Fisher Scientific stock worth more than $30,397,520 as of December 21st. This net worth approximation does not reflect any other assets that Mr. Stevenson may own. Learn More about Mark Stevenson's net worth.
How do I contact Mark Stevenson?: The corporate mailing address for Mr. Stevenson and other Thermo Fisher Scientific executives is 168 Third Avenue, Waltham MA, 02451. Thermo Fisher Scientific can also be reached via phone at (781) 622-1000 and via email at [email protected]. Learn More on Mark Stevenson's contact information.
Has Mark Stevenson been buying or selling shares of Thermo Fisher Scientific?: Mark Stevenson has not been actively trading shares of Thermo Fisher Scientific over the course of the past ninety days. Most recently, Mark Stevenson sold 26,925 shares of the business's stock in a transaction on Wednesday, December 1st. The shares were sold at an average price of $631.88, for a transaction totalling $17,013,369.00. Learn More on Mark Stevenson's trading history.
Who are Thermo Fisher Scientific's active insiders?: Thermo Fisher Scientific's insider roster includes Michael Boxer (SVP), Lisa Britt (Senior Vice President and Chief Human Resources Officer), Marc Casper (Chairman, President & CEO), Joseph Holmes (VP & CAO), Peter Hornstra (CAO), Syed Jafry (VP), Michel Lagarde (EVP), Jim Manzi (Director), Gianluca Pettiti (EVP), Debora Spar (Director), Mark Stevenson (COO), and Stephen Williamson (CFO). Learn More on Thermo Fisher Scientific's active insiders.
Are insiders buying or selling shares of Thermo Fisher Scientific?: During the last twelve months, insiders at the medical research company sold shares 22 times. They sold a total of 142,511 shares worth more than $81,094,921.00. The most recent insider tranaction occured on December, 2nd when CEO Marc N Casper sold 10,000 shares worth more than $5,302,600.00. Insiders at Thermo Fisher Scientific own 0.3% of the company. Learn More about insider trades at Thermo Fisher Scientific.
Information on this page was last updated on 12/2/2024.

Mark Stevenson Insider Trading History at Thermo Fisher Scientific

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2021	Sell	26,925	$631.88	$17,013,369.00
11/1/2021	Sell	26,925	$632.69	$17,035,178.25
12/7/2020	Sell	14,133	$473.84	$6,696,780.72	58,005
12/4/2020	Sell	14,113	$476.46	$6,724,279.98	58,005
8/25/2020	Sell	22,000	$420.16	$9,243,520.00	34,561
7/24/2020	Sell	25,000	$404.58	$10,114,500.00	73,621
4/24/2020	Sell	25,000	$328.03	$8,200,750.00	73,538

Mark Stevenson Buying and Selling Activity at Thermo Fisher Scientific

Thermo Fisher Scientific Company Overview

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $524.05

$515.00

$526.43

50 Day Range

MA: $543.04

$501.50

$603.79

2 Week Range

Now: $524.05

$493.30

$627.88

Volume

2,713,540 shs

Average Volume

1,556,857 shs

Market Capitalization

$200.45 billion

P/E Ratio

32.86

Dividend Yield

0.29%

Beta

0.77

First JFK… next Elon?

From Porter & Company | Ad